Emergent BioSolutions Praises Naloxone Accessibility in Congress
Emergent BioSolutions Inc. (NYSE: EBS) has recently expressed its recognition of a significant initiative in the U.S. House of Representatives: the addition of over-the-counter (OTC) naloxone at every AED location in its buildings. This move aims to ensure immediate availability for first responders and individuals who encounter someone potentially suffering from an opioid overdose, addressing a critical public health concern.
The Importance of Naloxone Access
The accessibility of life-saving treatments is essential in combating the opioid crisis that has affected many Americans. By expanding access to naloxone, Emergent continues its commitment to saving lives, with specific focus on its products, NARCAN® Nasal Spray and KLOXXADO® Nasal Spray. Emergent collaborates with key stakeholders dedicated to reducing the staggering number of overdose deaths, driven by the belief that every lost life is one too many.
Support for Legislative Efforts
Emergent acknowledges the leadership of Representative Buddy Carter, whose efforts have elevated this essential issue within the House. Joe Papa, the president and chief executive officer at Emergent, commended Carter’s initiative to make naloxone readily available as a means to potentially save lives during critical moments. Papa emphasized the impact of having naloxone accessible, noting that it is crucial as overdoses can occur unexpectedly to anyone, regardless of their situation.
Innovative Solutions for Opioid Overdose
In its mission to combat the opioid epidemic, Emergent launched NARCAN® Nasal Spray as the first OTC opioid overdose reversal tool in 2023. With over 85 million doses distributed across the U.S. and Canada since 2016, this product has become a pivotal resource in saving lives, particularly in overdose scenarios involving potent substances like fentanyl. As a leading supplier of nasal naloxone in the U.S., Emergent provides a diverse portfolio of products tailored for public interest groups, businesses, and healthcare providers.
Product Spotlight: NARCAN® and KLOXXADO®
- NARCAN® (naloxone HCl) Nasal Spray 4 mg (two-dose carton)
- NARCAN® Nasal Spray Wall Unit Kit: features a wall cabinet with an alarm system and informative signage
- KLOXXADO® (naloxone HCl) Nasal Spray 8 mg (two-dose carton)
- Convenience Kits: components such as a hard case containing CPR masks and gloves
Understanding Naloxone: A Lifesaving Medication
NARCAN® Nasal Spray is FDA-approved for emergency treatment of opioid overdoses and is available over the counter. Designed for easy use by the public, it provides an immediate response to someone experiencing an overdose. Importantly, it’s not a substitute for professional medical treatment and may require repeat doses under certain circumstances.
Safety Information for KLOXXADO® Nasal Spray
KLOXXADO® Nasal Spray, another essential product from Emergent, is utilized during opioid emergencies. It is crucial to administer this medication promptly and to seek medical help immediately following its use, even if the individual appears to recover.
Preparing for Opioid Overdoses: A Community Effort
The initiative to make naloxone accessible in places like the U.S. House of Representatives is a step towards fostering a culture of preparedness in times of crisis. Emergent BioSolutions remains at the forefront of efforts to educate communities about the importance of having naloxone on hand, equipping individuals with the knowledge and resources to respond effectively to opioid overdoses.
Commitment to Public Health
Emergent's overall mission extends beyond the production of medication. The organization seeks to empower communities, advocating for the widespread distribution of naloxone alongside educational efforts about opioid risks and overdose signs.
Frequently Asked Questions
What is the significance of OTC naloxone in public spaces?
Over-the-counter naloxone ensures that lifesaving medication is readily available to anyone who may encounter an overdose situation, thus enhancing community safety.
How many doses of NARCAN® have been distributed?
Since its launch, more than 85 million doses of NARCAN® have been distributed in the U.S. and Canada, emphasizing its role in fighting opioid overdose deaths.
What role does Emergent play in reducing overdose deaths?
Emergent works closely with health organizations and stakeholders to increase awareness and accessibility of naloxone, striving to save lives through proactive measures against opioid overdoses.
Are there any safety concerns with naloxone products?
While naloxone is generally safe, it may cause withdrawal symptoms in opioid-dependent individuals. Medical advice should be sought following administration of the medication.
How can individuals and businesses acquire naloxone?
Naloxone can be obtained at pharmacies as an OTC product, and organizations can work with Emergent for bulk supplies to ensure readiness in overdose emergencies.
